Chronic Neuropathic Pain clinical trials

Explore recruiting chronic neuropathic pain clinical trials.

Recruiting chronic neuropathic pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Neuropathic Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled 2-way crossover study to assess the analgesic effects of THC in patients with chronic neuropathic pain and to phenotype the responders to THC treatment.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A parallel-group treatment, proof-of-concept Phase 2, multicenter, double-blind, randomized 2 arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate or severe chronic neuropathic pain due to postherpetic neuralgia or peripheral nerve injury.

Germany, Bulgaria, Spain, Hungary, France, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-Δ tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

SerCaBot-2302 - Serratus Plane Block (SPB) versus Capsaicin versus Botulinum toxin type A for the chronic neuropathic pain of post-mastectomy syndrome

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Soothing Pain After ChEmotherapy: Psilocybin As INtervention (SPACE-PAIN) — a randomized controlled pilot trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

J4F-MC-CYAB: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study Evaluating LY3848575 in Chronic Neuropathic Pain Associated With Distal Sensory Polyneuropathy

Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Neuropathic Pain trials by city

Chronic Neuropathic Pain in Toronto Chronic Neuropathic Pain in Vancouver Chronic Neuropathic Pain in Montreal Chronic Neuropathic Pain in Calgary Chronic Neuropathic Pain in Edmonton Chronic Neuropathic Pain in Ottawa Chronic Neuropathic Pain in Winnipeg Chronic Neuropathic Pain in Quebec City Chronic Neuropathic Pain in Hamilton Chronic Neuropathic Pain in Kitchener Chronic Neuropathic Pain in London Chronic Neuropathic Pain in Halifax Chronic Neuropathic Pain in New York Chronic Neuropathic Pain in Los Angeles Chronic Neuropathic Pain in Chicago Chronic Neuropathic Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease